Follow
Thomas Liechti
Thomas Liechti
Scientist - Drug Development at Roche/Genentech
Verified email at roche.com
Title
Cited by
Cited by
Year
OMIP‐060: 30‐parameter flow cytometry panel to assess T cell effector functions and regulatory T cells
T Liechti, M Roederer
Cytometry Part A 95 (11), 1129-1134, 2019
552019
An updated guide for the perplexed: cytometry in the high-dimensional era
T Liechti, LM Weber, TM Ashhurst, N Stanley, M Prlic, S Van Gassen, ...
Nature Immunology 22 (10), 1190-1197, 2021
522021
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses
RD Kouyos, P Rusert, C Kadelka, M Huber, A Marzel, H Ebner, M Schanz, ...
Nature 561 (7723), 406-410, 2018
522018
OMIP-051–28-color flow cytometry panel to characterize B cells and myeloid cells
T Liechti, M Roederer
Cytometry. Part A: the journal of the International Society for Analytical …, 2019
462019
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity
C Kadelka, T Liechti, H Ebner, M Schanz, P Rusert, N Friedrich, ...
Journal of experimental medicine 215 (6), 1589-1608, 2018
362018
OMIP‐058: 30‐parameter flow cytometry panel to characterize iNKT, NK, unconventional and conventional T cells
T Liechti, M Roederer
Cytometry Part A 95 (9), 946-951, 2019
342019
Comprehensive phenotyping of human dendritic cells and monocytes
F Mair, T Liechti
Cytometry Part A 99 (3), 231-242, 2021
322021
High-throughput sequencing of human immunoglobulin variable regions with subtype identification
M Schanz, T Liechti, O Zagordi, E Miho, ST Reddy, HF Günthard, A Trkola, ...
PloS one 9 (11), e111726, 2014
292014
Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait
T Venkataraman, C Valencia, M Mangino, W Morgenlander, SJ Clipman, ...
Immunity 55 (1), 174-184. e5, 2022
272022
Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells
T Liechti, C Kadelka, DL Braun, H Kuster, J Böni, M Robbiani, ...
Journal of Experimental Medicine 216 (9), 2071-2090, 2019
262019
OMIP‐047: high‐dimensional phenotypic characterization of B cells
T Liechti, HF Günthard, A Trkola
Cytometry 93 (6), 592, 2018
212018
Development of a high-throughput bead based assay system to measure HIV-1 specific immune signatures in clinical samples
T Liechti, C Kadelka, H Ebner, N Friedrich, RD Kouyos, HF Günthard, ...
Journal of immunological methods 454, 48-58, 2018
162018
Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples
T Liechti, Y Iftikhar, M Mangino, M Beddall, CW Goss, JA O’Halloran, ...
Nature communications 13 (1), 7255, 2022
142022
The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation
K Zimmermann, T Liechti, A Haas, M Rehr, A Trkola, HF Günthard, ...
The Journal of Immunology 194 (2), 637-649, 2015
142015
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses
JW Angkeow, DR Monaco, A Chen, T Venkataraman, S Jayaraman, ...
Immunity 55 (6), 1051-1066. e4, 2022
132022
OMIP‐068: high‐dimensional characterization of global and antigen‐specific B cells in chronic infection
K Cascino, M Roederer, T Liechti
Cytometry Part A 97 (10), 1037-1043, 2020
122020
Systematic identification of genomic elements that regulate FCGR2A expression and harbor variants linked with autoimmune disease
J Dahlqvist, CP Fulco, JP Ray, T Liechti, CG de Boer, DJ Lieb, ...
Human Molecular Genetics 31 (12), 1946-1961, 2022
92022
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization
N Friedrich, E Stiegeler, M Glögl, T Lemmin, S Hansen, C Kadelka, Y Wu, ...
Nature Communications 12 (1), 6705, 2021
92021
Prevalence, persistence, and genetics of antibody responses to protein toxins and virulence factors
JW Angkeow, DR Monaco, A Chen, T Venkataraman, S Jayaraman, ...
Biorxiv, 2021.10. 01.462481, 2021
52021
Chagasic cardiomyopathy is marked by a unique signature of activated CD4+ T cells
GG Almeida, I Rimkute, INPC do Vale, T Liechti, PM Henriques, E Roffe, ...
Journal of Translational Medicine 20 (1), 551, 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20